<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03057392</url>
  </required_header>
  <id_info>
    <org_study_id>73/12</org_study_id>
    <nct_id>NCT03057392</nct_id>
  </id_info>
  <brief_title>Head Out Water Immersion for Hemodynamic Stability During Dialysis</brief_title>
  <official_title>The Effect of Head Out Water Immersion During Dialysis on Clinical Parameters, Hemodynamic Parameters, and Hormonal Parameters in 10 Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immersion to the neck before and during hemodialysis session may increase intravascular&#xD;
      volume, potentiate the ability to ultrafiltrate excess water, with less symptoms of shock,&#xD;
      muscle crumps etc.&#xD;
&#xD;
      The aim of the present study is to compare blood volume, hemodynamic and endocrine parameters&#xD;
      of chronic ESRD patients undergoing forth dialysis session in water immersion vs. control&#xD;
      regular session.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      10 chronic hemodialysis patients, treated in the hemodialysis unit of Asaf-Harofeh Medical&#xD;
      Center will be enrolled in the study.&#xD;
&#xD;
      Hemoglobin and albumin will be detected at baseline, and a recent (less than one year) echo&#xD;
      will be used for the detection of ejection fraction.&#xD;
&#xD;
      The study will be a cross over study. Each set of studies will consist of two dialysis&#xD;
      sessions, an immersion session, and a dry, non-immersion session. The study sessions will be&#xD;
      short, 3 hours sessions with 250-350 ml/min blood flow (depends on the patients access)&#xD;
      dialysate flow was 500 ml/min and dialysate sodium was 137meq/l. The temperature of the&#xD;
      dialysate will be adjusted to 37°C and its composition as follows: Na+ = 137 mEq/L, K+ = 2.0&#xD;
      mEq/L, Ca2+ = 3.0 mEq/L, Mg2+ = 1.0 mEq/L, HCO3-= 30 mEq/L, glucose =100 mg/dL, CH3COO-= 8&#xD;
      mEq/L. The sodium concentration will be constant during treatment.&#xD;
&#xD;
      Ultrafiltration will be determined as the mean of UF during the ten previous sessions±10%&#xD;
      according to the patients weight on admission. The immersed and dry session will be done in&#xD;
      the midweek sessions, in random order, at least one week apart from each other.&#xD;
&#xD;
      Head-Out Water Immersion&#xD;
&#xD;
      A bath will be used for immersion. The bath will be filled with purified water before each of&#xD;
      the session, and will be heated to 34-35°C. Patients will enter the bath and sat upright for&#xD;
      few minutes and then connected to dialysis. The water will circulate through a thermostats&#xD;
      and heating device in order to maintain a constant temperature.&#xD;
&#xD;
      Patients with arterio-venous fistula or graft in their arm will be immersed in water up to&#xD;
      their axilla, with their arm lining on a floating pad. For patients with perm-cath immersion&#xD;
      will only be done up to 5 cm below the catheter insertion.&#xD;
&#xD;
      Study procedure&#xD;
&#xD;
      Subjects will enter the bath and sit for few minutes, after which blood samples will be drown&#xD;
      for baseline measurement. During the session blood pressure and heart rate will be measured&#xD;
      every 15 minutes by conventional sphygmomanometry. and blood volume will be estimated by&#xD;
      using blood volume monitor (Crit-Line).&#xD;
&#xD;
      Blood samples will be drown at baseline and after one hour, and before caseation of the&#xD;
      session for plasma renin activity, aldosterone, atrial natriuretic peptide. Baseline and end&#xD;
      of session urea will also measured for URR.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>symptomatic hypotension during dialysis</measure>
    <time_frame>3 hours</time_frame>
    <description>a decrease of systolic BP of 22mmHG or more or decrease of diastolic BP of 10 mmHg or more accompanied with symptoms of muscle crumps, presyncope or syncope</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure changes compared to baseline</measure>
    <time_frame>3 hours every 15 min</time_frame>
    <description>analysis by electronic sphygmomanometer every 15 minutes during the session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial natriuretic peptide change compared to baseline</measure>
    <time_frame>0, 1, 3 hours</time_frame>
    <description>blood will be drown from arterial line at baseline, after one hour and after 3 hours before dialysis termination.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Intradialytic Hypotension</condition>
  <condition>Immersion</condition>
  <arm_group>
    <arm_group_label>immersion and them sham procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hemodialysis patients will do a 3 hours dialysis session while sitting in a bath and then have a &quot;dry session&quot; outside the bath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham session and then immersion</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>dialysis patients will have a 3 hour dialysis session (dry session) and then immersion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>immersion</intervention_name>
    <description>participants will sit in a 34-35C while receive dialysis</description>
    <arm_group_label>immersion and them sham procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham session</intervention_name>
    <description>dialysis while sitting in the dialysis chair</description>
    <arm_group_label>sham session and then immersion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  chronic hemodialysis patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  anemia (HB&lt;10) active infectious disease cognitive impairment dialysis access&#xD;
             installed in the leg inability to cooperate with the study procedure Clinically&#xD;
             evident overhydrated patients(edema, pulmonary congestion, pulmonary effusion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dialysis Clinic in Asaf Harofhe Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>June 11, 2014</study_first_submitted>
  <study_first_submitted_qc>February 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2017</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>immersion</keyword>
  <keyword>ultrafiltration</keyword>
  <keyword>dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

